DIVA Laboratories, Ltd. (TPEX:4153)
Taiwan · Delayed Price · Currency is TWD 32.00
-0.15 (-0.47%)
Sep 8, 2026, 1:30 PM CST
DIVA Laboratories Market Cap
DIVA Laboratories has a market cap or net worth of 1.88 billion as of September 8, 2026. Its market cap has decreased by -20.40% in one year.
Market Cap
1.88B
Enterprise Value
1.33B
Revenue
894.67M
Ranking
n/a
PE Ratio
19.63
Stock Price
32.00
ChartMarket Cap Chart
Since October 11, 2010, DIVA Laboratories's market cap has increased from 425.72M to 1.88B, an increase of 340.99%. That is a compound annual growth rate of 9.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 1.88B | -8.31% |
| Dec 31, 2025 | 2.05B | -8.76% |
| Dec 31, 2024 | 2.24B | 3.94% |
| Dec 29, 2023 | 2.16B | -9.25% |
| Dec 30, 2022 | 2.38B | 51.31% |
| Dec 30, 2021 | 1.57B | 8.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 2.95B |
| Puriblood Medical | 1.07B |
| Genetics Generation Advancement | 1.05B |
| Kim Forest Enterprise | 745.74M |
| Sofiva Genomics | 736.33M |
| TFBS Bioscience | 663.84M |
| Welgene Biotech | 379.86M |
| Pharmigene | 368.90M |